1. Home
  2. MLYS vs MOFG Comparison

MLYS vs MOFG Comparison

Compare MLYS & MOFG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MLYS
  • MOFG
  • Stock Information
  • Founded
  • MLYS 2019
  • MOFG 1934
  • Country
  • MLYS United States
  • MOFG United States
  • Employees
  • MLYS N/A
  • MOFG N/A
  • Industry
  • MLYS Biotechnology: Pharmaceutical Preparations
  • MOFG Major Banks
  • Sector
  • MLYS Health Care
  • MOFG Finance
  • Exchange
  • MLYS Nasdaq
  • MOFG Nasdaq
  • Market Cap
  • MLYS 634.6M
  • MOFG 608.5M
  • IPO Year
  • MLYS 2023
  • MOFG N/A
  • Fundamental
  • Price
  • MLYS $9.36
  • MOFG $27.96
  • Analyst Decision
  • MLYS Strong Buy
  • MOFG Buy
  • Analyst Count
  • MLYS 2
  • MOFG 2
  • Target Price
  • MLYS $30.00
  • MOFG $35.25
  • AVG Volume (30 Days)
  • MLYS 217.3K
  • MOFG 154.0K
  • Earning Date
  • MLYS 11-11-2024
  • MOFG 01-23-2025
  • Dividend Yield
  • MLYS N/A
  • MOFG 3.53%
  • EPS Growth
  • MLYS N/A
  • MOFG N/A
  • EPS
  • MLYS N/A
  • MOFG N/A
  • Revenue
  • MLYS N/A
  • MOFG $36,677,000.00
  • Revenue This Year
  • MLYS N/A
  • MOFG N/A
  • Revenue Next Year
  • MLYS N/A
  • MOFG $25.26
  • P/E Ratio
  • MLYS N/A
  • MOFG N/A
  • Revenue Growth
  • MLYS N/A
  • MOFG N/A
  • 52 Week Low
  • MLYS $7.95
  • MOFG $19.43
  • 52 Week High
  • MLYS $16.91
  • MOFG $34.56
  • Technical
  • Relative Strength Index (RSI)
  • MLYS 28.83
  • MOFG 29.70
  • Support Level
  • MLYS $12.00
  • MOFG $27.06
  • Resistance Level
  • MLYS $13.37
  • MOFG $28.95
  • Average True Range (ATR)
  • MLYS 0.94
  • MOFG 0.87
  • MACD
  • MLYS -0.29
  • MOFG -0.18
  • Stochastic Oscillator
  • MLYS 15.73
  • MOFG 26.47

About MLYS Mineralys Therapeutics Inc.

Mineralys Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing medicines to target diseases driven by abnormally elevated aldosterone. The company's product candidate, lorundrostat, is a proprietary, orally administered, selective aldosterone synthase inhibitor, that is initially developed for the treatment of patients with uncontrolled hypertension, defined as individuals who are unable to achieve BP of below 130/80 mmHg despite taking two or more lines of antihypertensive medication or resistant hypertension, defined as individuals who are unable to achieve BP of below 130/80 mmHg despite taking three or more antihypertensive medications typically including a diuretic.

About MOFG MidWestOne Financial Gp

MidWestOne Financial Group Inc is a bank holding company engaged in delivering relationship-based business and personal banking products and services. The Bank provides commercial loans, real estate loans, agricultural loans, credit card loans, and consumer loans. It also provides deposit products including demand and interest checking accounts, savings accounts, money market accounts, and time deposits. The Bank also provides products and services including treasury management, Zelle, online and mobile banking, debit cards, ATMs, and safe deposit boxes. The Bank offers its products and services through its network of full-service banking offices. the Bank's investments services department offers financial planning, investment advisory, and retail securities brokerage services.

Share on Social Networks: